ITM-55D

N/A

Report date: 2025/11/24 17:27:30

Base Information

Drug NameITM-55D
Drug Alias NameITM-55D
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsOvarian NeoplasmsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesITM Radiopharmazie Munchen GmbH
China Registration ClassN/A

Develop Information

Active CompaniesITM Radiopharmazie Munchen GmbH
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsAdenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A